Latest news
LigaChem Gains Sole Control of B7-H4 Cancer Drug With Distinct Tumor-Killing Mechanism - Tech TimesTech Times · Fri, 07 Aug 2026 18:29:26 GMTLigaChem Biosciences Takes Solo Control of ADC Cancer Drug After NextCure's Strategic Pivot - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 06:05:00 GMTLigaChem Bio Gains Sole Development Rights to Co-Developed ADC Drug - Seoul Economic DailySeoul Economic Daily · Fri, 07 Aug 2026 04:55:57 GMTLigachem Biosciences takes sole control of ADC LNCB74, pursues global licensing - CHOSUNBIZ - ChosunbizChosunbiz · Fri, 07 Aug 2026 02:15:00 GMTNextCure Provides Business Update and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:40 GMT